clinical trials

Roy Jensen, MD, Vice Chancellor and Director, The University of Kansas Cancer Center

By Roy Jensen, MD, Vice Chancellor and Director, The University of Kansas Cancer Center

I am thrilled to announce that The University of Kansas Cancer Center has achieved the National Cancer Institute’s (NCI) most prestigious designation: Comprehensive. This designation puts KU Cancer Center in the same league as our nation’s most elite cancer centers.

University of Kansas Cancer Center

The KU Clinical Research Center, supported by JCERT funding, offers cutting-edge clinical trials which lead to new cancer therapies every day. 

Kenneth Willard wasn’t even aware of a lump on his neck until his co-worker asked him about it. “I don’t know how he spotted the lump,” Willard recalled. “But I knew it needed to be checked out.” A visit with his primary doctor and an ear, nose and throat specialist followed. Biopsies revealed a diagnosis Willard never expected: At 55 years old, he had stage IV non-small cell lung cancer.

CiCi Rojas, president of Tico Productions

CiCi Rojas, president of Tico Productions, and a cancer survivor and former clinical trial participant, is helping lead a multicultural campaign in partnership with the KU Cancer Center to encourage clinical trial participation in minorities across the region.

Minority populations suffer from cancer disproportionately, yet current clinical research data for minorities is scarce. According to 2020 Food and Drug Administration data, 73% of clinical trial participants were white, 14% Asian, 6% Hispanic and 5% Black.

vice-chancellor of KU Cancer Center’s Clinical Trials Office, Natalie Streeter

New assistant vice-chancellor of KU Cancer Center’s Clinical Trials Office, Natalie Streeter, discusses the latest in breakthrough clinical trials and cancer research.

 At any given time, The University of Kansas Cancer Center is managing about 600 clinical trials across the cancer continuum, with approximately 250 of those trials actively enrolling participants.

KU Alzheimer's Disease Center

The KU Alzheimer’s Disease Center is using a three-year, $4.3 million award to help enhance its dementia research and care efforts across the city, state and region.

Scientists at the University of Kansas Alzheimer’s Disease Center (KC ADC) are convinced the path to beating back the life-robbing disease goes through clinical trials fueled by research volunteers willing to join the battle.

NCI map

The University of Kansas Cancer Center is the only NCI-designated cancer center in the region.

Team members at The University of Kansas Cancer Center are busy preparing their application for National Cancer Institute (NCI) designation renewal, a prestigious distinction held by only 70 other cancer centers in the United States.

Teri Banman, RN

Teri Banman, RN, oversees the Nurse Navigator Program at the KU Cancer Center, which pairs trained oncology nurses with patients to help guide them and their families through their cancer journeys.

When confronting cancer, it can be overwhelming to consider treatment options and discover clinical trial opportunities. That’s where a KU Cancer Center nurse navigator can help. 

Branda new lab coat crop

Joaquina Baranda, M.D., leads the KU Cancer Center’s early-phase clinical trial program, which is the first step in taking new therapies from the research lab to the patient

Decades of basic (or bench) science has built the foundational knowledge needed to make advancements in the diagnosis, treatment and prevention of diseases, including cancer. That preclinical research has led to early-phase clinical trials and today’s leading-edge cancer treatments at The University of Kansas Cancer Center.